Defective drug: Amiodarone, a widely use arrhythmia drug may increase cancer risk

A new study published in CANCER, a peer-reviewed journal of the American Cancer Society, shows that Amioradone, marketed since 1985 and used for arrhythmia or irregular heartbeats may increase cancer especially for patient using large doses.